Hepatitis C: how has France limited the expenses related to...

Expert Review of Pharmacoeconomics & Outcomes Research 2016 / 11 Vol. 16; Iss. 6

Hepatitis C: how has France limited the expenses related to new treatments?

Mouterde, Anne-Laure, Bocquet, François, Fusier, Isabelle, Paubel, Pascal
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Expert Review of Pharmacoeconomics & Outcomes Research
DOI:
10.1080/14737167.2016.1247696
Date:
November, 2016
File:
PDF, 665 KB
english, 2016
Conversion to is in progress
Conversion to is failed